HIV

ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1

By
1 Mins read
107
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced Read More

107
0
Share
Related posts
HIV

NACA assures Nigerians of steady supply of HIV drugs

By
1 Mins read
Reading Time: < 1 minute The National Agency for the Control of AIDS on Wednesday reassured Nigerians, particularly those living with HIV, that the country has a…
HIV

‘It’s back to drug rationing’: the end of HIV was in sight. Then came the cuts

By
1 Mins read
Reading Time: < 1 minute This year the world should have been “talking about the virtual elimination of HIV” in the near future.
HIV

US shutdown of HIV/Aids funding ‘could lead to 500,000 deaths in South Africa’

By
1 Mins read
Reading Time: < 1 minute Sweeping notices of termination of funding have been received by organisations working with HIV and Aids across Africa, with dire predictions of…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.